Author: Peter Mansell

Quintiles partners for Phase I unit in India

US-based contract research organisation (CRO) Quintiles Transnational has formed a partnership with Apollo Hospitals Group, the largest private hospital company in India, to set up a Phase I clinical trial unit in Hyderabad.

Read More

Geron trial approval marks new era for stem cell research

In a breakthrough hailed as a milestone for clinical research and the harbinger of a more accommodating US environment for stem cell research under the Obama administration, Geron Corporation has secured clearance from the Food and Drug Administration (FDA) for what the company says will be the world’s first study of a human embryonic stem cell (hESC)-based therapy in humans.

Read More

Immediate ban on primate research not feasible, says EU committee

Based on the available evidence, there appear to be “no valid scientific reasons” to “support a discontinuation of the use of primates in basic and applied research, or in the development and testing of new drugs”, concludes the European Union’s Scientific Committee on Health and Environmental Risks (SCHER).

Read More